Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 4 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Royalty Pharma plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 286 | 320 | +34 |
| Shares | 291.1M | 298.2M | +7.12M (+2.4%) |
| Value | $12.3B | $12.0B | −$269.8M (−2.2%) |
New holders (53)
Institutions that held Royalty Pharma plc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Royalty Pharma plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Alyeska Investment Group, L.P. | 354,729 | $14.9M |
| Advisory Resource Group | 61,601 | $2.59M |
| HRT Financial LP | 60,283 | $2.53M |
| Weiss Multi-Strategy Advisers LLC | 41,894 | $1.76M |
| FORA Capital, LLC | 41,084 | $1.73M |
| J. Goldman & Co LP | 38,599 | $1.62M |
| Twin Tree Management, LP | 36,004 | $1.51M |
| Maryland State Retirement & Pension System | 28,253 | $1.19M |
| Acadian Asset Management LLC | 24,571 | $1.03M |
| Gsa Capital Partners LLP | 12,874 | $541.0K |
| Wesbanco Bank Inc | 9,383 | $394.0K |
| Commerce Bank | 5,626 | $237.0K |
| Parsons Capital Management Inc | 4,859 | $204.0K |
| Greenleaf Trust | 4,786 | $201.0K |
| Gladius Capital Management LP | 932 | $40.0K |
| Venture Visionary Partners LLC | 100 | $4.20K |
| Benjamin F. Edwards & Company, Inc. | 43 | $2.00K |
| Concord Wealth Partners | 40 | $2.00K |
| Dark Forest Capital Management LP | 32 | $1.00K |